BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34047629)

  • 1. Cabazitaxel-loaded poly(alkyl cyanoacrylate) nanoparticles: toxicity and changes in the proteome of breast, colon and prostate cancer cells.
    Øverbye A; Torgersen ML; Sønstevold T; Iversen TG; Mørch Ý; Skotland T; Sandvig K
    Nanotoxicology; 2021 Sep; 15(7):865-884. PubMed ID: 34047629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants.
    Valsalakumari R; Pandya AD; Prasmickaite L; Kvalvaag A; Myrann AG; Åslund AKO; Kjos MS; Fontecha-Cuenca C; Haroon HB; Ribeiro ARS; Horejs-Hoeck J; Moghimi SM; Mørch Ý; Skotland T; Sandvig K; Mælandsmo GM; Iversen TG
    Int J Nanomedicine; 2024; 19():3009-3029. PubMed ID: 38562610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.
    Sulheim E; Baghirov H; von Haartman E; Bøe A; Åslund AK; Mørch Y; Davies Cde L
    J Nanobiotechnology; 2016 Jan; 14():1. PubMed ID: 26743777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft.
    Fusser M; Øverbye A; Pandya AD; Mørch Ý; Borgos SE; Kildal W; Snipstad S; Sulheim E; Fleten KG; Askautrud HA; Engebraaten O; Flatmark K; Iversen TG; Sandvig K; Skotland T; Mælandsmo GM
    J Control Release; 2019 Jan; 293():183-192. PubMed ID: 30529259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft.
    Pandya AD; Iversen TG; Moestue S; Grinde MT; Mørch Ý; Snipstad S; Åslund AKO; Øy GF; Kildal W; Engebråten O; Sandvig K; Skotland T; Mælandsmo GM
    Nanomaterials (Basel); 2021 Apr; 11(5):. PubMed ID: 33924869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
    Qu N; Lee RJ; Sun Y; Cai G; Wang J; Wang M; Lu J; Meng Q; Teng L; Wang D; Teng L
    Int J Nanomedicine; 2016; 11():3451-9. PubMed ID: 27555767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Variants of poly(alkylcyanoacrylate) Nanoparticles Differentially Affect LC3 and Autophagic Cargo Degradation.
    Sønstevold T; Engedal N; Mørch Ý; Iversen TG; Skotland T; Sandvig K; Torgersen ML
    J Biomed Nanotechnol; 2020 Apr; 16(4):432-445. PubMed ID: 32970976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models.
    Hyldbakk A; Fleten KG; Snipstad S; Åslund AKO; Davies CL; Flatmark K; Mørch Y
    Nanomedicine; 2023 Feb; 48():102656. PubMed ID: 36646195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles.
    Sulheim E; Iversen TG; To Nakstad V; Klinkenberg G; Sletta H; Schmid R; Hatletveit AR; Wågbø AM; Sundan A; Skotland T; Sandvig K; Mørch Ý
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel cyanoacrylate monomers for use in nanoparticle drug delivery systems prepared by miniemulsion polymerisation - A multistep screening approach.
    Hyldbakk A; Mørch Y; Snipstad S; Åslund AKO; Klinkenberg G; Nakstad VT; Wågbø AM; Schmid R; Molesworth PP
    Int J Pharm X; 2022 Dec; 4():100124. PubMed ID: 35898812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects.
    Kommineni N; Mahira S; Domb AJ; Khan W
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30934535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel.
    Qu N; Sun Y; Xie J; Teng L
    Anticancer Agents Med Chem; 2017; 17(2):294-300. PubMed ID: 27225451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer.
    Hoang B; Ernsting MJ; Tang WS; Bteich J; Undzys E; Kiyota T; Li SD
    Cancer Lett; 2017 Dec; 410():169-179. PubMed ID: 28965854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
    Huang CY; Lee YD
    Int J Pharm; 2006 Nov; 325(1-2):132-9. PubMed ID: 16857330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines.
    Mura S; Fattal E; Nicolas J
    J Drug Target; 2019; 27(5-6):470-501. PubMed ID: 30720372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
    Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
    Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines.
    Chand P; Kumar H; Badduri N; Gupta NV; Bettada VG; Madhunapantula SV; Kesharwani SS; Dey S; Jain V
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111535. PubMed ID: 33360926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular detection of PEBCA particles in macrophages: combining darkfield microscopy, confocal Raman microscopy, and ToF-SIMS analysis.
    Vennemann A; Breitenstein D; Tallarek E; Mørch Ý; Schmid R; Wiemann M
    Drug Deliv Transl Res; 2022 Sep; 12(9):2075-2088. PubMed ID: 35182369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery.
    Fleten KG; Hyldbakk A; Einen C; Benjakul S; Strand BL; Davies CL; Mørch Ý; Flatmark K
    Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
    Begemann D; Wang Y; Yang W; Kyprianou N
    Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.